To determine the clinical relevance of the above findings in NSCLC patients, we first analyzed USP5 copy number of TCGA samples using UCSC-xena platform and found that USP5 is genomically amplified in NSCLC (Fig. 6A). The gene discussed is USP5; the disease is non-small cell lung carcinoma.